🟢 Alzamend Neuro is trading 8% up in pre-market; catalyst remains unclear

Alzamend Neuro is trading 8.24% up at $1.84 with no clearly identifiable company-specific catalyst on September 3, 2026.

• A September 3 report highlighted Alzamend’s previously announced September 29 presentation of AL001 imaging data in Barcelona; the underlying announcement was published August 18, 2026, so it is not fresh news.
• Major indexes are up roughly 0.11% to 0.22%, offering limited support for the move.